<scp>SRC</scp> inhibition represents a potential therapeutic strategy in liposarcoma
Elisabeth Sievers(University Hospital Bonn), Wolfgang Hartmann(University of Münster)
Cited by 24
Related Papers
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups
|PLoS ONE|2015|228
Phosphatidylinositol‐3′‐kinase/AKT signaling is essential in synovial sarcoma
|International Journal of Cancer|2010|52
SS18-SSX drives CREB activation in synovial sarcoma
|Cellular Oncology|2022|9